| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9308 |
| Human Intestinal Absorption | HIA+ | 0.9745 |
| Caco-2 Permeability | Caco2+ | 0.7151 |
| P-glycoprotein Substrate | Non-substrate | 0.6465 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7684 |
| Non-inhibitor | 0.8162 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8914 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8897 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8206 |
| CYP450 2D6 Substrate | Non-substrate | 0.8820 |
| CYP450 3A4 Substrate | Non-substrate | 0.6097 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5666 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6604 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9218 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7906 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8983 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7003 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9738 |
| Non-inhibitor | 0.9621 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.5391 |
| Fish Toxicity | High FHMT | 0.9862 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9669 |
| Honey Bee Toxicity | High HBT | 0.6573 |
| Biodegradation | Ready biodegradable | 0.6348 |
| Acute Oral Toxicity | IV | 0.7836 |
| Carcinogenicity (Three-class) | Non-required | 0.5420 |